Engineers Gate Manager’s ClearPoint Neuro CLPT Stock Holding History

Engineers Gate Manager’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,307	Closed	-$219K	–	2214
2025 Q2	$219K	Buy	+18,307	New	+$230K	﹤0.01%	1866
2022 Q1	–	Sell	-52,603	Closed	-$590K	–	1912
2021 Q4	$590K	Buy	+52,603	New	+$787K	0.03%	938

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Engineers Gate Manager's CLPT Position: Q3 2025 in Review

Engineers Gate Manager sold out of ClearPoint Neuro (CLPT) in Q3 2025, closing a stake of 18,307 shares — an estimated $219K sold.

Engineers Gate Manager first reported a position in CLPT in Q4 2021 and held it in 2 quarters. The position peaked at $590K in Q4 2021. 107 funds tracked by Wall St. Rank hold CLPT as of Q3 2025.

Engineers Gate Manager reported no remaining ClearPoint Neuro position as of Q3 2025 after selling out during the quarter.
Engineers Gate Manager sold 18,307 ClearPoint Neuro shares in Q3 2025, an estimated $219K.
Engineers Gate Manager first reported a position in ClearPoint Neuro in Q4 2021 and held it in 2 quarters.
Engineers Gate Manager's ClearPoint Neuro position peaked at $590K in Q4 2021.
107 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.